DECIPHER LABS LIMITED Share Price

DECIPHER LABS LIMITED Share Price

BSE: 524752
|
Pharmaceuticals
|
S Cap
₹ 5.63
+0.00 (0.00%)
1D
Last updated 02 Sep, 2026, 15:15 IST

--
0.00% up today
--
1D LOW
1D HIGH

DECIPHER LABS LIMITED Returns Calculator


Circuit
L
H
₹4.51
₹6.75
52-week
L
H
₹5.00
₹11.20

About DECIPHER LABS LIMITED

DECIPHER LABS LIMITED Share Price
ISIN
INE643N01012
Sector Market Cap
₹ 5.69 Cr

Decipher Labs Limited is an India-based company, which is engaged in the manufacture and marketing of pharmaceuticals and allied products and services. The Company’s segment includes pharmaceuticals and consultancy. It also provides services to the information technology industry. The Company also caters to various formulators, manufacturers and research and development agencies for their bulk needs and sources and supplies various drugs and allied chemicals and allied products and services to the companies upon request. The Company offers a range of services, including technology integration and systems consulting, software development consulting, and management of information technology (IT) projects. The Company’s wholly owned subsidiary is Decipher Software Solutions LLC.

DECIPHER LABS LIMITED Financial Highlights

  • Revenue: DECIPHER LABS LIMITED reported revenue of ₹14.27 crore in FY26 vs ₹23.93 crore in FY25. It showed a decrease of 40.37% on a yearly basis.
  • Operating Profit: DECIPHER LABS LIMITED reported an operating loss of ₹3.68 crore in FY26 vs ₹6.39 crore in FY25. It showed an increase of 42.41% on a year-on-year basis.
  • Net Profit: DECIPHER LABS LIMITED reported a net loss of ₹3.08 crore in FY26 vs ₹5.08 crore in FY25. It showed an increase of 39.37% on a yearly basis.

DECIPHER LABS LIMITED Quarterly Result Highlights

  • DECIPHER LABS LIMITED reported revenue of ₹2.51 crore in Jun 2026, compared with ₹3.77 crore in Mar 2026, representing a decrease of 33.42% on a quarter-on-quarter (QoQ) basis.
  • DECIPHER LABS LIMITED reported an operating loss of ₹2.19 crore in Jun 2026, compared with ₹0.25 crore in Mar 2026, representing a decrease of 976.00% on a quarter-on-quarter (QoQ) basis.
  • DECIPHER LABS LIMITED reported a loss of ₹2.19 crore in Jun 2026, compared with ₹0.36 crore in Mar 2026, reflecting a decrease of 508.33% on a QoQ basis.
  • The earnings per share (EPS) of DECIPHER LABS LIMITED stood at ₹5.03 during Jun 2026.
Know more
Promoters
16.43%
FII
0.00%
Other DII
0.00%
Retail and other
83.57%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
5.69

P/E
-1.86

P/B
0.28

ROE
-14.93%

D/E
0.06

ROCE
-17.41%

Div. Yield
0.00%

EPS(TTM)
-0.24
Turnover
0.04

EV/EBITDA
-2.70

Net Margin
0.00%

Op. Margin
0.00%

ROA
-12.62%

Quick Ratio
0.00

Curr. Ratio
0.67
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Decipher Labs has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Decipher Labs appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
Decipher Labs earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,63,180.0038.285.5513.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,43,302.0083.7914.6215.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,623.0088.2922.6425.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,16,114.0025.004.2418.59%0.3117.35%237.300.09%0.3335.38
Cipla1,14,554.0034.023.3211.27%0.0014.95%423.360.92%0.4543.52
Laurus Labs1,00,660.0092.3218.9916.77%0.4016.14%97.200.11%0.6713.72
Lupin98,312.2017.734.3823.76%0.0424.88%659.000.84%0.57129.18
Dr. Reddy's Laboratories96,906.3030.442.5511.07%0.1812.54%377.950.69%0.4138.68
Mankind Pharma97,467.0047.546.0311.74%0.3413.13%397.020.04%0.4449.37
Aurobindo Pharma96,836.1025.682.529.25%0.1911.76%394.820.24%0.3841.58

DECIPHER LABS LIMITED Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹22.61₹35.88₹45.57₹65.32
Other Income₹1.32₹0.42₹7.37₹7.67
Total Revenue₹23.93₹36.30₹52.94₹73.00
Total Expenses₹30.32₹37.51₹54.86₹60.64
Profit Before Tax-₹6.39-₹1.21-₹4.16₹12.36
Tax-₹1.31₹0.46-₹1.48₹0.97
Profit After Tax-₹5.08-₹1.68-₹2.68₹11.38
EPS - Basic-₹5.03-₹1.66-₹2.66₹11.27
EPS - Diluted-₹5.03-₹1.66-₹2.66₹11.27

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹6.39-₹1.21-₹4.16₹12.36
Income before WC changes₹0.34-₹0.21-₹6.87₹7.02
Change in Assets-₹1.09-₹2.70₹8.50₹0.35
Change in Liabilities-₹9.06₹7.77-₹3.19₹0.89
Change in WC-₹10.16₹5.07₹5.30₹1.25
Cash flow from Operations-₹9.82₹4.85-₹1.56₹8.26
Cash flow from Investing₹3.07-₹1.79-₹4.28-₹0.45
Cash flow from Financing₹0.24-₹1.17-₹2.15₹1.30
Total Cash Flow-₹6.51₹1.90-₹7.99₹9.11
Cash (Start of the year)₹9.31₹7.42₹15.41₹6.98
Cash (End of the year)₹2.81₹9.31₹7.42₹15.41

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹4.71₹8.96₹8.08₹3.72
Current Assets₹21.05₹24.68₹20.08₹38.23
Total Assets₹25.76₹33.63₹28.16₹41.95
Current Liabilities₹2.91₹11.77₹4.96₹11.11
Net Current Asset₹18.14₹12.91₹15.13₹27.12
Non-Current Liabilities₹0.00₹0.00₹0.00₹6.68
Equity Capital₹22.86₹21.86₹23.21₹24.17
Total Equity & Liabilities₹25.76₹33.63₹28.16₹41.95

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹0.85₹3.53₹0.81₹0.99
Other Income₹0.02₹0.02₹0.03₹0.05
Total Revenue₹0.88₹3.55₹0.84₹1.03
Total Expenses₹1.31₹3.53₹1.24₹0.68
Profit Before Tax-₹0.44₹0.03-₹2.64₹0.36
Tax₹0.00₹0.00-₹0.02₹0.00
Profit After Tax-₹0.44₹0.02-₹2.62₹0.36
EPS - Basic-₹0.44₹0.02-₹2.59₹0.36
EPS - Diluted-₹0.44₹0.02-₹2.59₹0.36

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹0.44₹0.03-₹2.64₹0.36
Income before WC changes-₹0.43₹0.04-₹0.27₹0.42
Change in Assets₹3.64-₹3.82₹0.19₹0.12
Change in Liabilities-₹3.14₹3.75₹0.01₹0.01
Change in WC₹0.50-₹0.07₹0.19₹0.13
Cash flow from Operations₹0.07-₹0.03-₹0.08₹0.55
Cash flow from Investing-₹0.05₹0.00₹0.09-₹0.38
Cash flow from Financing₹0.00₹0.00₹0.00-₹0.14
Total Cash Flow₹0.03-₹0.03₹0.01₹0.03
Cash (Start of the year)₹0.03₹0.06₹0.05₹0.02
Cash (End of the year)₹0.05₹0.03₹0.06₹0.05

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹8.85₹8.79₹8.81₹9.00
Current Assets₹0.32₹3.97₹0.18₹2.60
Total Assets₹9.18₹12.76₹8.99₹11.60
Current Liabilities₹0.69₹3.83₹0.09₹0.08
Net Current Asset-₹0.37₹0.14₹0.10₹2.52
Non-Current Liabilities₹0.00₹0.00₹0.00₹0.00
Equity Capital₹8.49₹8.93₹8.90₹11.52
Total Equity & Liabilities₹9.18₹12.76₹8.99₹11.60
* All values are in INR Crore
Qty
Bid
199
5.2
300
5.01
800
4.6
500
4.52
0
0
Ask
Qty
6.75
300
0
0
0
0
0
0
0
0
Bid Total: 1799
Ask Total: 300
Buy orders: 86%
Sell orders: 14%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
42.54
Neutral

ATR (14)
0.29
Neutral

STOCH(9,6)
56.47
Neutral

STOCH RSI (14)
74.99
Neutral

ADX(9)
51.81
Bearish

UO(9)
59.45
Neutral

ROC(12)
-4.25
Bearish

WillR(14)
-58.26
Neutral
Period
Simple value
Exponential vaue

5D
5.6
5.59

10D
5.67
5.68

20D
5.92
5.85

50D
6.25
6.19

100D
6.79
6.61
Volume trend — traded volume by day
2 Sep0L
1 Sep0L
31 Aug0L
28 Aug0L
27 Aug0L
Average0L
Compare against other stocks
DECIPHER LABS LIMITED Share Price
DECIPHER LABS LIMITED
Pharmaceuticals
Add Stock
Add Another

DECIPHER LABS LIMITED Share Price FAQs